These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7702225)
41. Cost Effectiveness of HIV Prevention Interventions in the U.S. Lin F; Farnham PG; Shrestha RK; Mermin J; Sansom SL Am J Prev Med; 2016 Jun; 50(6):699-708. PubMed ID: 26947213 [TBL] [Abstract][Full Text] [Related]
42. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. Schulman KA; Lynn LA; Glick HA; Eisenberg JM Ann Intern Med; 1991 May; 114(9):798-802. PubMed ID: 1672806 [TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Lazenby GB; Unal ER; Andrews AL; Simpson K Sex Transm Dis; 2014 Jun; 41(6):353-8. PubMed ID: 24827616 [TBL] [Abstract][Full Text] [Related]
44. The cost-effectiveness of HIV testing: accounting for differential participation rates. Paltiel AD; Kaplan EH Med Decis Making; 1997; 17(4):490-5. PubMed ID: 9343808 [TBL] [Abstract][Full Text] [Related]
45. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356 [TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Lin OS; Keeffe EB; Sanders GD; Owens DK Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169 [TBL] [Abstract][Full Text] [Related]
47. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Hu D; Hook EW; Goldie SJ Ann Intern Med; 2004 Oct; 141(7):501-13. PubMed ID: 15466767 [TBL] [Abstract][Full Text] [Related]
48. Economic evaluation of HIV testing among intravenous drug users. An analytic framework and its application to Italy. Villari P; Fattore G; Siegel JE; Paltiel AD; Weinstein MC Int J Technol Assess Health Care; 1996; 12(2):336-57. PubMed ID: 8707505 [TBL] [Abstract][Full Text] [Related]
49. Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model. Bell DM; Shapiro CN; Culver DH; Martone WJ; Curran JW; Hughes JM Infect Agents Dis; 1992 Oct; 1(5):263-9. PubMed ID: 1344665 [TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China. Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489 [TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study. Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809 [TBL] [Abstract][Full Text] [Related]
52. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention. Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101 [TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care. Mrus JM; Tsevat J Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952 [TBL] [Abstract][Full Text] [Related]
54. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India. Kumar M; Birch S; Maturana A; Gafni A Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300 [TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana). van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ Value Health; 2008; 11(5):809-19. PubMed ID: 18489518 [TBL] [Abstract][Full Text] [Related]
56. HIV transmission during invasive radiologic procedures: estimate based on computer modeling. Hansen ME; McIntire DD AJR Am J Roentgenol; 1996 Feb; 166(2):263-7. PubMed ID: 8553928 [TBL] [Abstract][Full Text] [Related]
57. Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty? Winkelmann M; Sorrentino JN; Klein M; Macke C; Mommsen P; Brand S; Schröter C; Krettek C; Zeckey C Orthop Traumatol Surg Res; 2016 Jun; 102(4):513-6. PubMed ID: 27062330 [TBL] [Abstract][Full Text] [Related]
58. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation? Mabileau G; Schwarzinger M; Flores J; Patrat C; Luton D; Epelboin S; Mandelbrot L; Matheron S; Yazdanpanah Y Am J Obstet Gynecol; 2015 Sep; 213(3):341.e1-12. PubMed ID: 25979615 [TBL] [Abstract][Full Text] [Related]
59. Cost effectiveness of cervical cancer screening for the elderly. Fahs MC; Mandelblatt J; Schechter C; Muller C Ann Intern Med; 1992 Sep; 117(6):520-7. PubMed ID: 1503355 [TBL] [Abstract][Full Text] [Related]
60. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong. Lee PM; Wong KH Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]